No
Non verificato

NorthStar Medical Radioisotopes, LLC

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina nucleareOncologiaSalute
28/05/2026
Industria
Scienza
Sanità
Biotecnologia
Medicina nucleare
Farmaceutica
Salute
Oncologia
Mercato del lavoro
Low Institute for Therapeutics and NorthStar Partner to Advance Novel Radioligand Therapy for Cancer-Associated Bone Disease
1.00
27/05/2026
Mercato del lavoro
Industria
Oncologia
Salute
Sanità
Medicina nucleare
Farmaceutica
Biotecnologia
NorthStar and QSA Global Announce Multi-Year Strategic Partnership to Strengthen Actinium-225 Supply Chain for Targeted Alpha Therapies
1.00
15/04/2026
Scienza
Medicina nucleare
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
NorthStar Secures FDA Acceptance of Drug Master File for No-Carrier-Added Actinium-225
1.00
06/01/2026
Mercato del lavoro
Industria
Oncologia
Salute
Medicina - Varie
Medicina nucleare
Farmaceutica
Biotecnologia
Convergent Therapeutics and NorthStar Medical Radioisotopes Announce Expanded Partnership to Support Convergent's Late-Stage Alpha-Emitting Radioantibody Program
1.00
06/01/2026
Oncologia
Salute
Medicina - Varie
Medicina nucleare
Farmaceutica
Biotecnologia
Industria
NorthStar Medical Radioisotopes Confirms Successful Routine Commercial-scale Ac-225 Production
1.00
17/12/2025
Eventi
Biotecnologia
Salute
Medicina nucleare
Farmaceutica
Oncologia
NorthStar Medical Radioisotopes to Present at the 44th Annual J.P. Morgan Healthcare Conference
1.00
16/12/2025
Mercato del lavoro
Oncologia
Salute
Medicina nucleare
Scienza
Farmaceutica
Biotecnologia
Kathy Spencer-Pike Joins NorthStar Medical Radioisotopes, LLC as Chief Commercial Officer
1.00
16/12/2025
Mercato del lavoro
Medicina nucleare
Biotecnologia
Farmaceutica
Sanità
Oncologia
Salute
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
1.00
23/09/2025
Mercato del lavoro
Industria
Scienza
Sanità
Medicina nucleare
Farmaceutica
Oncologia
Università
Scuola/Istruzione
Medicina - Varie
Biotecnologia
Salute
NorthStar Medical Radioisotopes, LLC and University of Wisconsin School of Medicine and Public Health Enter Strategic Partnership to Advance Radiopharmaceutical Research, Innovation and Talent Development
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0